JavaScript seems to be disabled in your browser. You must have JavaScript enabled in your browser to utilize the functionality of this website.
Description: ABT-288 is a novel, potent and highly selective histamine-3 receptor antagonist which demonstrated efficacy across several preclinical cognitive domains, and safety in healthy subjects and elderly volunteers. However, it did not demonstrate efficacy in the symptomatic treatment of Alzheimer's dementia in a randomized, double-blind, placebo- and active-controlled, parallel group design with pre-defined futility criteria to permit early study termination.
References: J Alzheimers Dis. 2014; 42(3):959-71.
Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.
All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.
Request Data Sheet
Request product datasheet
Request safety datasheet
Compare
Add to wishlist
Get an offer
Request delivery time
Ask a technical question
Submit a bulk request
sales@hoelzel.de
« Back
Subscribe, get 15% off every fifth order and have your items delivered on time!
Forgot Your Password?
Not yet registered? Create account here!